Ablation of Rotor and Focal Sources Reduces Late Recurrence of Atrial Fibrillation Compared With Trigger Ablation Alone: Extended Follow-Up of the CONFIRM Trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation)

The aim of this study was to determine if ablation that targets patient-specific atrial fibrillation (AF)-sustaining substrates (rotors or focal sources) is more durable than trigger ablation alone at preventing late AF recurrence. Late recurrence substantially limits the efficacy of pulmonary vein...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2014-05, Vol.63 (17), p.1761-1768
Hauptverfasser: NARAYAN, Sanjiv M, BAYKANER, Tina, CLOPTON, Paul, SCHRICKER, Amir, LALANI, Gautam G, KRUMMEN, David E, SHIVKUMAR, Kalyanam, MILLER, John M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1768
container_issue 17
container_start_page 1761
container_title Journal of the American College of Cardiology
container_volume 63
creator NARAYAN, Sanjiv M
BAYKANER, Tina
CLOPTON, Paul
SCHRICKER, Amir
LALANI, Gautam G
KRUMMEN, David E
SHIVKUMAR, Kalyanam
MILLER, John M
description The aim of this study was to determine if ablation that targets patient-specific atrial fibrillation (AF)-sustaining substrates (rotors or focal sources) is more durable than trigger ablation alone at preventing late AF recurrence. Late recurrence substantially limits the efficacy of pulmonary vein isolation for AF and is associated with pulmonary vein reconnection and the emergence of new triggers. Three-year follow-up was performed of the CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial, in which 92 consecutive patients with AF (70.7% persistent) underwent novel computational mapping. Ablation comprised source (focal impulse and rotor modulation [FIRM]) and then conventional ablation in 27 patients (FIRM guided) and conventional ablation alone in 65 patients (FIRM blinded). Patients were followed with implanted electrocardiographic monitors when possible (85.2% of FIRM-guided patients, 23.1% of FIRM-blinded patients). FIRM mapping revealed a median of 2 (interquartile range: 1 to 2) rotors or focal sources in 97.7% of patients during AF. During a median follow-up period of 890 days (interquartile range: 224 to 1,563 days), compared to FIRM-blinded therapy, patients receiving FIRM-guided ablation maintained higher freedom from AF after 1.2 ± 0.4 procedures (median 1; interquartile range: 1 to 1) (77.8% vs. 38.5%, p = 0.001) and a single procedure (p < 0.001) and higher freedom from all atrial arrhythmias (p = 0.003). Freedom from AF was higher when ablation directly or coincidentally passed through sources than when it missed sources (p < 0.001). FIRM-guided ablation is more durable than conventional trigger-based ablation in preventing 3-year AF recurrence. Future studies should investigate how ablation of patient-specific AF-sustaining rotors and focal sources alters the natural history of arrhythmia recurrence. (The Dynamics of Human Atrial Fibrillation; NCT01008722).
doi_str_mv 10.1016/j.jacc.2014.02.543
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1521329513</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1521329513</sourcerecordid><originalsourceid>FETCH-LOGICAL-p241t-288c6e1e4435c5a2a76d13d2f8dad22a848500136d9ec53b9a49e6c9ef7c89193</originalsourceid><addsrcrecordid>eNptUctu1DAUDS_RofADLJA3SGWR4Eec2OxGUQdGmlJpaMVy5LFv2oySOHVsaP8epxPKhtXR1T2Pe3ST5D3BGcGk-HzIDkrrjGKSZ5hmPGfPkwXhXKSMy_JlssAl4ynBsjxJ3ozjAWNcCCJfJyc0LxilAi-evVjuW-Ub2yNbo6311iHVG7SyWrXohw1Ow4i2YMKEG-UhDjo4B72GSbL0ronMVbN3TTs7VbYblAODfjb-Fl255uYGHHoKWra2hy_o_N5Db2DKalv7O70eJj9_C6i6_L5aby8mZbQ-q2z_C_pJGqcnlzpe-r_wx8y4m9AGPzdZd0NoR3jsdmx5YU04Sj69TV7VKm7fzXiaXK_Or6pv6eby67pabtKB5sSnVAhdAIE8Z1xzRVVZGMIMrYVRhlIlcsExJqwwEjRne6lyCYWWUJdaSCLZaXJ29B2cvQsw-l3XjBri5T3YMO4Ip4RRyQmL1A8zNew7MLvBNZ1yD7u_j4uEjzNBjbFg7VSvm_EfT-QlxYKxP7K1qzc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1521329513</pqid></control><display><type>article</type><title>Ablation of Rotor and Focal Sources Reduces Late Recurrence of Atrial Fibrillation Compared With Trigger Ablation Alone: Extended Follow-Up of the CONFIRM Trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation)</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>NARAYAN, Sanjiv M ; BAYKANER, Tina ; CLOPTON, Paul ; SCHRICKER, Amir ; LALANI, Gautam G ; KRUMMEN, David E ; SHIVKUMAR, Kalyanam ; MILLER, John M</creator><creatorcontrib>NARAYAN, Sanjiv M ; BAYKANER, Tina ; CLOPTON, Paul ; SCHRICKER, Amir ; LALANI, Gautam G ; KRUMMEN, David E ; SHIVKUMAR, Kalyanam ; MILLER, John M</creatorcontrib><description>The aim of this study was to determine if ablation that targets patient-specific atrial fibrillation (AF)-sustaining substrates (rotors or focal sources) is more durable than trigger ablation alone at preventing late AF recurrence. Late recurrence substantially limits the efficacy of pulmonary vein isolation for AF and is associated with pulmonary vein reconnection and the emergence of new triggers. Three-year follow-up was performed of the CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial, in which 92 consecutive patients with AF (70.7% persistent) underwent novel computational mapping. Ablation comprised source (focal impulse and rotor modulation [FIRM]) and then conventional ablation in 27 patients (FIRM guided) and conventional ablation alone in 65 patients (FIRM blinded). Patients were followed with implanted electrocardiographic monitors when possible (85.2% of FIRM-guided patients, 23.1% of FIRM-blinded patients). FIRM mapping revealed a median of 2 (interquartile range: 1 to 2) rotors or focal sources in 97.7% of patients during AF. During a median follow-up period of 890 days (interquartile range: 224 to 1,563 days), compared to FIRM-blinded therapy, patients receiving FIRM-guided ablation maintained higher freedom from AF after 1.2 ± 0.4 procedures (median 1; interquartile range: 1 to 1) (77.8% vs. 38.5%, p = 0.001) and a single procedure (p &lt; 0.001) and higher freedom from all atrial arrhythmias (p = 0.003). Freedom from AF was higher when ablation directly or coincidentally passed through sources than when it missed sources (p &lt; 0.001). FIRM-guided ablation is more durable than conventional trigger-based ablation in preventing 3-year AF recurrence. Future studies should investigate how ablation of patient-specific AF-sustaining rotors and focal sources alters the natural history of arrhythmia recurrence. (The Dynamics of Human Atrial Fibrillation; NCT01008722).</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2014.02.543</identifier><identifier>PMID: 24632280</identifier><identifier>CODEN: JACCDI</identifier><language>eng</language><publisher>New York, NY: Elsevier</publisher><subject>Atrial Fibrillation - physiopathology ; Atrial Fibrillation - surgery ; Biological and medical sciences ; Cardiac dysrhythmias ; Cardiology. Vascular system ; Catheter Ablation - methods ; Electrocardiography ; Female ; Follow-Up Studies ; Heart ; Heart Conduction System - physiopathology ; Heart Conduction System - surgery ; Humans ; Male ; Medical sciences ; Middle Aged ; Prospective Studies ; Pulmonary Veins - surgery ; Secondary Prevention ; Time Factors ; Treatment Outcome</subject><ispartof>Journal of the American College of Cardiology, 2014-05, Vol.63 (17), p.1761-1768</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=28472083$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24632280$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>NARAYAN, Sanjiv M</creatorcontrib><creatorcontrib>BAYKANER, Tina</creatorcontrib><creatorcontrib>CLOPTON, Paul</creatorcontrib><creatorcontrib>SCHRICKER, Amir</creatorcontrib><creatorcontrib>LALANI, Gautam G</creatorcontrib><creatorcontrib>KRUMMEN, David E</creatorcontrib><creatorcontrib>SHIVKUMAR, Kalyanam</creatorcontrib><creatorcontrib>MILLER, John M</creatorcontrib><title>Ablation of Rotor and Focal Sources Reduces Late Recurrence of Atrial Fibrillation Compared With Trigger Ablation Alone: Extended Follow-Up of the CONFIRM Trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation)</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description>The aim of this study was to determine if ablation that targets patient-specific atrial fibrillation (AF)-sustaining substrates (rotors or focal sources) is more durable than trigger ablation alone at preventing late AF recurrence. Late recurrence substantially limits the efficacy of pulmonary vein isolation for AF and is associated with pulmonary vein reconnection and the emergence of new triggers. Three-year follow-up was performed of the CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial, in which 92 consecutive patients with AF (70.7% persistent) underwent novel computational mapping. Ablation comprised source (focal impulse and rotor modulation [FIRM]) and then conventional ablation in 27 patients (FIRM guided) and conventional ablation alone in 65 patients (FIRM blinded). Patients were followed with implanted electrocardiographic monitors when possible (85.2% of FIRM-guided patients, 23.1% of FIRM-blinded patients). FIRM mapping revealed a median of 2 (interquartile range: 1 to 2) rotors or focal sources in 97.7% of patients during AF. During a median follow-up period of 890 days (interquartile range: 224 to 1,563 days), compared to FIRM-blinded therapy, patients receiving FIRM-guided ablation maintained higher freedom from AF after 1.2 ± 0.4 procedures (median 1; interquartile range: 1 to 1) (77.8% vs. 38.5%, p = 0.001) and a single procedure (p &lt; 0.001) and higher freedom from all atrial arrhythmias (p = 0.003). Freedom from AF was higher when ablation directly or coincidentally passed through sources than when it missed sources (p &lt; 0.001). FIRM-guided ablation is more durable than conventional trigger-based ablation in preventing 3-year AF recurrence. Future studies should investigate how ablation of patient-specific AF-sustaining rotors and focal sources alters the natural history of arrhythmia recurrence. (The Dynamics of Human Atrial Fibrillation; NCT01008722).</description><subject>Atrial Fibrillation - physiopathology</subject><subject>Atrial Fibrillation - surgery</subject><subject>Biological and medical sciences</subject><subject>Cardiac dysrhythmias</subject><subject>Cardiology. Vascular system</subject><subject>Catheter Ablation - methods</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart</subject><subject>Heart Conduction System - physiopathology</subject><subject>Heart Conduction System - surgery</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Prospective Studies</subject><subject>Pulmonary Veins - surgery</subject><subject>Secondary Prevention</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptUctu1DAUDS_RofADLJA3SGWR4Eec2OxGUQdGmlJpaMVy5LFv2oySOHVsaP8epxPKhtXR1T2Pe3ST5D3BGcGk-HzIDkrrjGKSZ5hmPGfPkwXhXKSMy_JlssAl4ynBsjxJ3ozjAWNcCCJfJyc0LxilAi-evVjuW-Ub2yNbo6311iHVG7SyWrXohw1Ow4i2YMKEG-UhDjo4B72GSbL0ronMVbN3TTs7VbYblAODfjb-Fl255uYGHHoKWra2hy_o_N5Db2DKalv7O70eJj9_C6i6_L5aby8mZbQ-q2z_C_pJGqcnlzpe-r_wx8y4m9AGPzdZd0NoR3jsdmx5YU04Sj69TV7VKm7fzXiaXK_Or6pv6eby67pabtKB5sSnVAhdAIE8Z1xzRVVZGMIMrYVRhlIlcsExJqwwEjRne6lyCYWWUJdaSCLZaXJ29B2cvQsw-l3XjBri5T3YMO4Ip4RRyQmL1A8zNew7MLvBNZ1yD7u_j4uEjzNBjbFg7VSvm_EfT-QlxYKxP7K1qzc</recordid><startdate>20140506</startdate><enddate>20140506</enddate><creator>NARAYAN, Sanjiv M</creator><creator>BAYKANER, Tina</creator><creator>CLOPTON, Paul</creator><creator>SCHRICKER, Amir</creator><creator>LALANI, Gautam G</creator><creator>KRUMMEN, David E</creator><creator>SHIVKUMAR, Kalyanam</creator><creator>MILLER, John M</creator><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20140506</creationdate><title>Ablation of Rotor and Focal Sources Reduces Late Recurrence of Atrial Fibrillation Compared With Trigger Ablation Alone: Extended Follow-Up of the CONFIRM Trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation)</title><author>NARAYAN, Sanjiv M ; BAYKANER, Tina ; CLOPTON, Paul ; SCHRICKER, Amir ; LALANI, Gautam G ; KRUMMEN, David E ; SHIVKUMAR, Kalyanam ; MILLER, John M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p241t-288c6e1e4435c5a2a76d13d2f8dad22a848500136d9ec53b9a49e6c9ef7c89193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Atrial Fibrillation - physiopathology</topic><topic>Atrial Fibrillation - surgery</topic><topic>Biological and medical sciences</topic><topic>Cardiac dysrhythmias</topic><topic>Cardiology. Vascular system</topic><topic>Catheter Ablation - methods</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart</topic><topic>Heart Conduction System - physiopathology</topic><topic>Heart Conduction System - surgery</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Prospective Studies</topic><topic>Pulmonary Veins - surgery</topic><topic>Secondary Prevention</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>NARAYAN, Sanjiv M</creatorcontrib><creatorcontrib>BAYKANER, Tina</creatorcontrib><creatorcontrib>CLOPTON, Paul</creatorcontrib><creatorcontrib>SCHRICKER, Amir</creatorcontrib><creatorcontrib>LALANI, Gautam G</creatorcontrib><creatorcontrib>KRUMMEN, David E</creatorcontrib><creatorcontrib>SHIVKUMAR, Kalyanam</creatorcontrib><creatorcontrib>MILLER, John M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>NARAYAN, Sanjiv M</au><au>BAYKANER, Tina</au><au>CLOPTON, Paul</au><au>SCHRICKER, Amir</au><au>LALANI, Gautam G</au><au>KRUMMEN, David E</au><au>SHIVKUMAR, Kalyanam</au><au>MILLER, John M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ablation of Rotor and Focal Sources Reduces Late Recurrence of Atrial Fibrillation Compared With Trigger Ablation Alone: Extended Follow-Up of the CONFIRM Trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation)</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2014-05-06</date><risdate>2014</risdate><volume>63</volume><issue>17</issue><spage>1761</spage><epage>1768</epage><pages>1761-1768</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><coden>JACCDI</coden><abstract>The aim of this study was to determine if ablation that targets patient-specific atrial fibrillation (AF)-sustaining substrates (rotors or focal sources) is more durable than trigger ablation alone at preventing late AF recurrence. Late recurrence substantially limits the efficacy of pulmonary vein isolation for AF and is associated with pulmonary vein reconnection and the emergence of new triggers. Three-year follow-up was performed of the CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial, in which 92 consecutive patients with AF (70.7% persistent) underwent novel computational mapping. Ablation comprised source (focal impulse and rotor modulation [FIRM]) and then conventional ablation in 27 patients (FIRM guided) and conventional ablation alone in 65 patients (FIRM blinded). Patients were followed with implanted electrocardiographic monitors when possible (85.2% of FIRM-guided patients, 23.1% of FIRM-blinded patients). FIRM mapping revealed a median of 2 (interquartile range: 1 to 2) rotors or focal sources in 97.7% of patients during AF. During a median follow-up period of 890 days (interquartile range: 224 to 1,563 days), compared to FIRM-blinded therapy, patients receiving FIRM-guided ablation maintained higher freedom from AF after 1.2 ± 0.4 procedures (median 1; interquartile range: 1 to 1) (77.8% vs. 38.5%, p = 0.001) and a single procedure (p &lt; 0.001) and higher freedom from all atrial arrhythmias (p = 0.003). Freedom from AF was higher when ablation directly or coincidentally passed through sources than when it missed sources (p &lt; 0.001). FIRM-guided ablation is more durable than conventional trigger-based ablation in preventing 3-year AF recurrence. Future studies should investigate how ablation of patient-specific AF-sustaining rotors and focal sources alters the natural history of arrhythmia recurrence. (The Dynamics of Human Atrial Fibrillation; NCT01008722).</abstract><cop>New York, NY</cop><pub>Elsevier</pub><pmid>24632280</pmid><doi>10.1016/j.jacc.2014.02.543</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2014-05, Vol.63 (17), p.1761-1768
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_miscellaneous_1521329513
source MEDLINE; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Atrial Fibrillation - physiopathology
Atrial Fibrillation - surgery
Biological and medical sciences
Cardiac dysrhythmias
Cardiology. Vascular system
Catheter Ablation - methods
Electrocardiography
Female
Follow-Up Studies
Heart
Heart Conduction System - physiopathology
Heart Conduction System - surgery
Humans
Male
Medical sciences
Middle Aged
Prospective Studies
Pulmonary Veins - surgery
Secondary Prevention
Time Factors
Treatment Outcome
title Ablation of Rotor and Focal Sources Reduces Late Recurrence of Atrial Fibrillation Compared With Trigger Ablation Alone: Extended Follow-Up of the CONFIRM Trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T17%3A48%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ablation%20of%20Rotor%20and%20Focal%20Sources%20Reduces%20Late%20Recurrence%20of%20Atrial%20Fibrillation%20Compared%20With%20Trigger%20Ablation%20Alone:%20Extended%20Follow-Up%20of%20the%20CONFIRM%20Trial%20(Conventional%20Ablation%20for%20Atrial%20Fibrillation%20With%20or%20Without%20Focal%20Impulse%20and%20Rotor%20Modulation)&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=NARAYAN,%20Sanjiv%20M&rft.date=2014-05-06&rft.volume=63&rft.issue=17&rft.spage=1761&rft.epage=1768&rft.pages=1761-1768&rft.issn=0735-1097&rft.eissn=1558-3597&rft.coden=JACCDI&rft_id=info:doi/10.1016/j.jacc.2014.02.543&rft_dat=%3Cproquest_pubme%3E1521329513%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1521329513&rft_id=info:pmid/24632280&rfr_iscdi=true